Umoja Biopharma Presents Data on its Engineered Induced Pluripotent Stem Cell Platform at the 2022 International Society for Stem Cell Research Annual Meeting

3 years ago

SEATTLE, June 16, 2022 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune…

ABVC BioPharma Submitted Vitargus® Phase II Study Plan to Australia HREC

3 years ago

FREMONT, CA, June 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical…

WIMI Hologram Academy: The Application of Virtual reality online games in Information Communication in the 5G era

3 years ago

HONG KONG, June 16, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,…

22nd Century Group (Nasdaq: XXII) Appoints R. Hugh Kinsman as CFO

3 years ago

CFO of GVB Biopharma to Expand Role, Become CFO of 22nd Century GroupIntegration of GVB Biopharma Proceeding at a Rapid…

PepGen Reports First Quarter 2022 Financial Results and Recent Corporate Developments

3 years ago

BOSTON, June 16, 2022 (GLOBE NEWSWIRE) -- PepGen Inc. (“PepGen”), a clinical-stage biotechnology company advancing the next generation of oligonucleotide…

Broken Coast Cannabis Launches Full Spectrum ‘woah’

3 years ago

A New Summer Lineup of Premium Craft-Cannabis Products Including, Liquid Wax, BHO Vapes, and Premium Small-Batch Flower Now Available Across…

Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an Effective Approach to Targeting Carcinoma Catabolism

3 years ago

Cranbury, N.J., June 16, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer…

INmune Bio, Inc. Presents Data on Combination Therapy with INB03™ on Overcoming Resistance to HER2 Targeted Therapies in Breast Cancer

3 years ago

In pre-clinical models of trastuzumab resistant MUC4 HER2+ breast cancer, treatment with INB03™ decreases MUC4 expression, reverses resistance to trastuzumab…

Nova Mentis Files Patent on Diagnosing, Monitoring and Treating Neurological Diseases with Psychoactive Tryptamine Derivatives

3 years ago

mRNA Diagnostic Index to Measure Drug Treatment ResponseVancouver, British Columbia--(Newsfile Corp. - June 16, 2022) - Nova Mentis Life Science…

CBD of Denver Accelerates Expansion Plans with Strategic Priorities Set for Second Half of 2022

3 years ago

Denver, Colorado--(Newsfile Corp. - June 16, 2022) -  CBD of Denver, Inc. (OTC Pink: CBDD), a cannabis roll-up company and…